iData Research

iData Research

November 29, 2010 07:45 ET

Survey Reveals Cardiologist Preference for Bioabsorbable Stents Will Fuel Interventional Cardiology Market by 2013

Increase in Angioplasty Procedures Fuels U.S. Drug-Eluting Stent Market to Almost $2.5 Billion

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 29, 2010) - According to a comprehensive global survey on stents, stent-grafts and vulnerable plaque by iData Research (, the leading global authority in medical device and pharmaceutical market research, the majority of cardiologists in the U.S., Europe, China, India, Middle East and Africa would use a bioabsorbable stent for the treatment of coronary angioplasty. In contrast, the majority of cardiologist in Japan and Latin-America would not use a bioabsorbable stent.

A recent report released by iData Research on the interventional cardiology market revealed that bioabsorbable stents are expected to enter the European market by 2013 and the U.S. thereafter. The U.S. market is estimated to quickly reach almost $750 million with companies such as Abbott Laboratories (NYSE:ABT), Biosensors International, and REVA Medical emerging as leaders.

iData's survey details the preferences and usage patterns from hundreds of cardiologists worldwide for bioabsorbable, bifurcated and drug-eluting stents, stent-grafts and vulnerable plaque treatment. 

"The survey provided dramatic differences between geographical regions in usage trends," says Dr. Kamran Zamanian, CEO of iData. "Cardiologists in the U.S. and Europe are more willing to use new technologies such as bifurcated and bioabsorbable stents, while Japanese and Latin American cardiologists are more resistant, citing the lack of long-term clinical data, early recoil and technical challenges as drawbacks to these technologies."

iData's accompanying market report states that the U.S. market for interventional cardiology is expected to reach almost $5 billion by 2017, with increasing drug-eluting stent sales and the emergence of bioabsorbable and bifurcated stents fueling market growth.

iData's global cardiologist survey series includes: "Stents, Stent-Grafts and Vulnerable Plaque Treatment" and "Deep-Vein Thrombosis Treatment and Screening". These surveys accompany iData's newest global 3-report series on the "Markets for Interventional Cardiology Devices".

For more information, register free on iData's website at: 

About iData Research

iData Research ( is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: interventional cardiology, peripheral-vascular, vascular-access, cardiac surgery and more.

Contact Information